CORT's Q4 Earnings and Revenues Fall Short of Estimates

Corcept Therapeutics Incorporated (CORT) reported fourth-quarter 2024 earnings of 26 cents per share, which missed the Zacks Consensus Estimate of 37 cents. The company had reported earnings of 28 cents per share in the year-ago quarter.See the Zacks Earnings Calendar to stay ahead of market-making news.Revenues in the fourth quarter increased 34.3% year over year to $181.9 million. However, the figure missed the Zacks Consensus Estimate of$196 million. The top line solely comprises product sales of the Cu ...